Delirium after COVID‑19

Why delirium can appear during or after COVID‑19 and what to do next.

Key points

• In older or frail patients, delirium may be an early or predominant manifestation of COVID‑19, sometimes without fever.
• COVID‑associated delirium is usually multifactorial: hypoxaemia, systemic inflammation, dehydration, sleep disruption, immobility and medication burden often coexist.
• Any new delirium should be managed as a time‑critical clinical problem: identify reversible causes, assess complications and ensure safety.

Clinical context

COVID‑19 is a systemic illness. In susceptible patients—particularly those with frailty, dementia, multimorbidity or recent hospitalisation—acute brain dysfunction may present as delirium (fluctuating inattention, altered consciousness and disorganised thinking). Delirium can occur early in infection, during hospital/ICU care, or during recovery when residual hypoxia, inflammation, weakness and polypharmacy persist.

Pathophysiology

Current models frame delirium as a failure of brain network integration under systemic stress. In COVID‑19, key contributors include neuroinflammation (cytokine‑mediated signalling and barrier dysfunction), hypoxaemia and impaired cerebral perfusion, toxic‑metabolic disturbances (electrolytes, renal/hepatic dysfunction) and drug effects (sedatives, opioids, anticholinergics). Environmental factors—sleep deprivation, isolation, sensory deprivation and immobility—further lower cognitive reserve.

Risk factors & triggers

• Age > 65, frailty, dementia, prior delirium, sensory impairment.
• Pneumonia, low oxygen saturation, thromboembolic or cardiac complications.
• Dehydration, poor oral intake, fever, diarrhoea/vomiting.
• Polypharmacy; recent medication changes; sedatives/hypnotics and anticholinergic burden.
• Pain, urinary retention, constipation, sleep–wake disruption.

Assessment

Confirm delirium clinically (e.g., 4AT/CAM in healthcare settings) and search systematically for precipitating factors. Practical first steps: check oxygen saturation, temperature, heart rate and blood pressure; review respiratory symptoms and hydration; perform a focused medication reconciliation including over‑the‑counter sleep aids. In clinical care, common tests include CBC, CRP, electrolytes, glucose, renal and liver function; consider blood gas analysis, chest imaging and cultures as indicated. Maintain a low threshold for evaluating serious complications when the clinical picture suggests them.

Management

Management is cause‑directed: correct hypoxaemia, treat pneumonia/bacterial superinfection when indicated, rehydrate, correct electrolytes and glucose, manage pain, relieve urinary retention/constipation and optimise sleep. Non‑pharmacological strategies are foundational: frequent reorientation, daylight exposure, quiet nights, early mobilisation, and use of glasses/hearing aids. Sedating medication is reserved for severe agitation threatening safety and should be clinician‑directed, with attention to QT prolongation, parkinsonism and respiratory depression.

Common pitfalls

• Attributing confusion to “post‑viral fatigue” and missing hypoxaemia or sepsis.
• Adding sedatives without addressing triggers (hypoxia, dehydration, medications, environment).
• Missing hypoactive delirium (“just sleeping”), which can signal severe illness.

Practical tables

Related topics

Delirium: practical overview • Causes • Delirium with infection • Dehydration & electrolytes